Found 89 matching trials
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients PHASE3 This is a multicenter, randomized controlled, phase III clinical trial. The...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. PHASE3 The trial aimed to compare QL1706 combined with induction chemotherapy plus...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma PHASE2 This study is designed prospectively to investigate the safety and efficacy...
Show More Location
Shanghai Renji Hospital
Learn More & Join Trial
Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma N/A The program aims to enroll patients with stage high risk (AJCC 8th, T3-4N2-...
Show More Location
Guangxi Medical University Cancer Hospital
Learn More & Join Trial
Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC PHASE2 TOPAZ-1 phase III trail demonstrated that the addition of immune checkpoint...
Show More Location
Eastern hepatobilliary surgery hospital
Learn More & Join Trial
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors PHASE1 The main purpose of this study is to establish the safety and the recommend...
Show More Status
Active Not Recruiting
Location
HonorHealth Research Institute
Learn More & Join Trial
Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma PHASE3 This study is a randomized, placebo-controlled, double-blind, multicenter p...
Show More Location
Cancer Center of Sun-Yat Sen University (CCSYSU)
Learn More & Join Trial
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI PHASE2 The goal of this open-label randomized, multicenter, comparative phase II t...
Show More Location
Institut de Cancérologie de l'Ouest
Learn More & Join Trial
PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma PHASE1 At present, the treatment regimen of locally advanced nasopharyngeal carcin...
Show More Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Learn More & Join Trial
The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma PHASE3 A multicenter, prospective, randomized, open-label, controlled trial to eva...
Show More Learn More & Join Trial